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Abstract
Snake venoms are rich sources of biologically active proteins and polypeptides. Three-finger toxins are non-enzymatic
proteins present in elapid (cobras, kraits, mambas and sea snakes) and colubrid venoms. These proteins contain four
conserved disulfide bonds in the core to maintain the three-finger folds. Although all three-finger toxins have similar fold,
their biological activities are different. A new three-finger toxin (hemachatoxin) was isolated from Hemachatus haemachatus
(Ringhals cobra) venom. Its amino acid sequence was elucidated, and crystal structure was determined at 2.43 A˚ resolution.
The overall fold is similar to other three-finger toxins. The structure and sequence analysis revealed that the fold is
maintained by four highly conserved disulfide bonds. It exhibited highest similarity to particularly P-type cardiotoxins that
are known to associate and perturb the membrane surface with their lipid binding sites. Also, the increased B value of
hemachotoxin loop II suggests that loop II is flexible and may remain flexible until its interaction with membrane
phospholipids. Based on the analysis, we predict hemachatoxin to be cardiotoxic/cytotoxic and our future experiments will
be directed to characterize the activity of hemachatoxin.
Citation: Girish VM, Kumar S, Joseph L, Jobichen C, Kini RM, et al. (2012) Identification and Structural Characterization of a New Three-Finger Toxin Hemachatoxin
from Hemachatus haemachatus Venom. PLoS ONE 7(10): e48112. doi:10.1371/journal.pone.0048112
Editor: Alejandra Bravo, Universidad Nacional Autonoma de Mexico, Instituto de Biotecnologia, Mexico
Received April 28, 2012; Accepted September 19, 2012; Published October 29, 2012
Copyright:  2012 Girish et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: JS acknowledges the funding support from Academic Research Fund (R154000438112). RMK was supported by Bio-Medical Research Council (BMRC -
A*STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dbskinim@nus.edu.sg (RMK); dbsjayar@nus.edu.sg (JS)
. These authors contributed equally to this work.
¤ Current address: Scientific Services, Biopolis Shared Facility, Singapore, Singapore
Introduction
Snake venoms are rich sources of biologically active proteins
and polypeptides [1]. Apart from its crucial role in paralyzing and
digesting prey, snake venom is also an excellent source for novel
toxins. Understanding the mechanisms of action of unique toxins,
helps in the discovery of novel receptors and in the development of
lead therapeutic molecules [2,3]. Snake venom toxins can be
broadly categorized as enzymatic and non-enzymatic proteins.
They are also classified into various toxin superfamilies. Each
superfamily contains structurally similar toxins that exhibit varied
pharmacological activities. Some of the well characterized
superfamilies of snake venom proteins include three-finger toxins
(3FTxs), C-type lectin like proteins (CLPs), phospholipase A2s
(PLA2s), serine proteases and metalloproteases [4–6]. 3FTxs, non-
enzymatic snake venom proteins, are the most abundant toxins
found in elapid (cobras, kraits, mambas and sea snakes) and
colubrid venoms [4,7]. Besides they have been reported from
viperid venoms [8,9]. 3FTxs are composed of 60–74 amino acid
residues and 4–5 disulfide bridges. Structurally, all 3FTxs have a
stable fold with three b-stranded loops extending from a central
core containing all four conserved disulphide bridges, resembling
the three fingers of a hand, and hence their common name
[10,11]. The conserved cysteine residues, along with invariant
residues, such as Tyr25 and Phe27, contribute to proper folding
[12]. Some 3FTxs have an additional fifth disulfide in loop I and II
as in the case of non-conventional toxins and long-chain
neurotoxins, respectively [11,13]. In general, 3FTxs exist as
monomers. However, a few of them exist as homo- or hetero-
dimers in which the subunits are held together by either non-
covalent interactions or by covalent (disulfide) linkages. For
example, k-bungarotoxin [14] and haditoxin [15] exist as non-
covalent homodimers where the individual subunits are structur-
ally related to long-chain and short-chain neurotoxins, respective-
ly. The individual subunits are arranged in anti-parallel orienta-
tion and are held together mostly by hydrogen bonds between
main-chain and side-chain atoms [15–17]. On the other hand,
covalently linked 3FTxs include the homodimeric a-cobratoxin (a-
CT) [18] and the heterodimeric irditoxin [19]. The structural
analysis of the homodimeric a-CT [18] reveals the presence of a b-
strand swap as well as two disulfide linkages between loop I of the
individual subunits, thereby stabilizing the entire dimeric structure
[20]. In irditoxin, the individual subunits are covalently linked
through a single disulfide bond between loop I (of irditoxin B) and
loop II (of irditoxin A) [19]. 3FTxs also exhibit minor structural
variations in the length and conformation of the loops, and
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presence of longer C-terminal or N-terminal extensions (for
details, see [4]). Despite overall similar fold, 3FTxs recognize a
broad range of distinct molecular targets resulting in diverse
biological activities [21,22]. Based on their biological properties,
3FTxs can be classified as postsynaptic neurotoxins targeting the
nicotinic [23] and muscarinic [24] acetylcholine receptors,
cardiotoxins/cytotoxins targeting phospholipid membranes [25],
fasciculins targeting acetylcholinesterase (AChE) [26], calciseptins
and FS2 toxins targeting L-type calcium channels [27,28],
anticoagulants like naniproin, exactin and siamextin [R. M. Kini
and colleagues, unpublished data] targeting various coagulation
complexes, b-blockers like b-cardiotoxin targeting b1- and b2-
adrenergic receptors [29], dendroaspin targeting aIIbb3 (glycopro-
tein IIB-IIIa) [30], cardiotoxin A5 targeting avb3 integrins [31]
and antagonists of a1A [32] and a2A [33]adrenergic receptors. The
ability of 3FTxs to recognize various molecular targets signifies the
need for understanding structure-function relationships of these
toxins. The three-finger fold is also observed in various other
proteins like xenoxins from X. laevis [34] and HEP21 from hen egg
white [35], as well as mammalian Ly-6 alloantigens [36],
urokinase-plasminogen activator receptor [37] and complement
regulatory protein CD59 [38]. 3FTxs in snake venoms are thought
to be evolved from non-toxic ancestral proteins through gene
duplication and accelerated evolution [39,40].
In continuation of our efforts to understand the relationship
between the structure and function of 3FTxs [4,7,15], we isolated,
purified and determined the complete amino acid sequence and
the crystal structure of a new three-finger toxin (hemachatoxin)
from H. haemachatus (Ringhals cobra) venom at 2.43 A˚ resolution.
The overall fold of hemachatoxin is similar to other known 3FTxs.
The structure and sequence analysis revealed that the fold is
maintained by four conserved disulfide bonds. Our efforts on the
structure and sequence analyses combined with literature suggest-
ed that the unique biological activities of the 3FTxs are associated
with the subtle conformational differences in the three b-strand
loops. In addition, our analysis suggests that hemachatoxin might
be endowed with cardiotoxic/cytotoxic activity.
Results
Isolation and Purification of Hemachatoxin
The H. haemachatus crude venom was fractionated on a gel
filtration (Superdex 30) column. Peak 3 (Figure 1A) from gel
filtration chromatography contained proteins that mostly belong
to 3FTx family. Hemachatoxin (black arrow) was purified from peak
3 on a C18 reverse-phase column (Figure 1B) and further purified
to homogeneity using a shallow gradient on the same column
(Figure 1C). The homogeneity and mass of hemachatoxin was
Figure 1. Purification of hemachatoxin from the venom of H. haemachatus. (A) Size-exclusion chromatogram of the crude venom. The
proteins were eluted using 50 mM Tris-HCl, pH 7.4 and monitored at 280 nm. The fractions of peak 3 (black horizontal bar) were pooled and sub-
fractionated on RP-HPLC. (B) RP-HPLC chromatogram of peak 3 using a linear gradient of 28–50% solvent B. The elution was monitored at 215 nm.
The black arrow indicates the elution of hemachatoxin. (C) The re-purification of hemachatoxin on a shallow gradient of 35–45% solvent B. The
elution was monitored at 215 nm. (D) The ESI-MS profile of hemachatoxin showing the three peaks of mass/charge (m/z) ratio ranging from +4 to +6
charges. The mass of hemachatoxin was determined to be 6835.6860.94 Da.
doi:10.1371/journal.pone.0048112.g001
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determined by electrospray ionization mass spectrometry (ESI-
MS). ESI-MS showed 3 peaks of mass/charge (m/z) ratio ranging
from +4 to +6 charges (Figure 1D). The mass was calculated to be
6835.6860.94 Da.
Sequence Determination and Analysis
We determined the complete amino acid sequence of
hemachatoxin by automated Edman degradation. The first 45
amino acid residues were determined by sequencing the native
protein while the remaining sequence was determined from
overlapping fragments of chemically-cleaved S-pyridylethylated
hemachatoxin (Figure S1A,S1B, S2) (Table S1). The calculated
mass of 6836.4 Da from the hemachatoxin sequence agrees well
with the experimentally determined molecular mass
(6835.6860.94 Da). The crystal structure (see below) with well
defined electron density for the entire hemachatoxin molecule was
used to confirm the experimentally determined sequence of the
protein as described earlier [41]. The BLAST search [42] showed
that hemachatoxin is closely related (.70% identity) to cardiotox-
ins/cytotoxins, a subgroup of 3FTxs (Figure 2A). Hemachatoxin
exhibited highest identity to cytotoxin 1 (97%) [43], cytotoxin 2
(89%) and cytotoxin 3 (84%) [44], purified from Hemachatus
haemachatus venom. Hemachatoxin differs from cytotoxin 1 [43] in
two amino acid positions (Leu27Met28 is replaced by Me-
t27Leu28). This difference was confirmed by ESI-MS (CNBr
cleavage site and mass of peptides, Table S1), Edman degradation
(Figure S3A, S3B and S3C) and electron density map (see below).
Thus hemachatoxin belongs to the 3FTx family based on sequence
similarity and the position of cysteine residues (Figure 2).
Structural Analysis
The structure of hemachatoxin was determined by the
molecular replacement method using Naja nigricollis toxin-c
coordinates (PDB code 1TGX) as a search model. There were
two hemachatoxin molecules in an asymmetric unit with each
molecule consisting of residues from Leu1 to Asn61 (Figure 3A).
Both monomers are well defined in the electron density map
(Figure 3B). The model was refined to a final R value of 0.23
(Rfree = 0.28) (Table 1). The stereochemical parameters of the
model were analyzed by PROCHECK [45] and all residues are in
the allowed regions of the Ramachandran plot. Each monomer of
the asymmetric unit consists of 6 anti-parallel b-strands
(b2Qb1qb4Qb3qb6Qb5q) that form two b-sheets
(Figure 3A). The first b-sheet consists of two anti-parallel b-
strands, b1 (Lys2-Lys6) and b2 (Phe10-Thr14), while the second
contains four anti-parallel strands, b3 (Leu21-Thr26), b4 (Ile35-
Thr40), b5 (Ala42-Ser47) and b6 (Lys51-Asn56). The fold of
hemachatoxin is maintained by four disulfide bonds, and these
cysteines are strictly conserved among the 3FTxs. The three
fingers of hemachatoxin consist of the secondary structures
b1Vb2, b3Vb4 and b5Vb6 (Figure 3A). The electrostatic surface
representation shows that loops I and II are predominantly
charged residues, whereas loop III is highly hydrophobic in nature
(Figure 3C). The sequence alignment revealed the conserved
Figure 2. Multiple sequence alignment of hemachatoxin with cardiotoxins/cytotoxins (A) and other three-finger toxins (B). Toxin
names, species and accession numbers are shown. Conserved residues in all the sequences are highlighted in black. The type of cardiotoxin based on
the conserved Pro31 is highlighted in grey. Disulfide linkages and loop regions are also shown. The sequence identity (in percentage) of each protein
with hemachatoxin is shown at the end of each sequence.
doi:10.1371/journal.pone.0048112.g002
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residues of hemachatoxin as well as its identity to cardiotoxins/
cytotoxins (Figure 4A). Also, hemachatoxin shared the common
three-finger fold and molecular shape when compared to its
structural homologues (Figure 4B) [46].
Discussion
The three-dimensional structures of snake venom 3FTxs,
particularly that of neurotoxins [15,20,47,48] and cardiotoxins/
cytotoxins [49–52] have been extensively studied. Here we report
the structural characterization of a new 3FTx, hemachatoxin from
the venom of H. haemachatus. The structural analyses indicate that
hemachatoxin belongs to cardiotoxin/cytotoxin subgroup of 3FTx
family. It exhibited 97% sequence identity to cytotoxin 1 [43],
whose crystal structure has not been determined. ESI-MS, Edman
degradation and crystal structure data indicates that hemacha-
toxin differs from cytotoxin 1 in two amino acid positions
(Leu27Met28 is replaced by Met27Leu28) and hence are isoforms.
Multiple isoforms of 3FTxs are known to be present in single snake
venom [53,54].
As mentioned in the introduction section, 3FTxs, including
hemachatoxin, share overall structural similarity (Figure 4B), but
they differ from each other in their biological activities. Subtle
variations in the size and conformation of b-sheet loops dictate the
biological specificities in 3FTxs. For example, the well character-
ized long-chain (e.g. a-cobratoxin, a-bungarotoxin) and short-
chain (e.g. erabutoxin a, toxin-a) neurotoxins that differ in loop
size and length of C-terminal extension, exhibit distinct specificity
for nAChR subtypes. Short-chain neurotoxins has a longer loop I
(12–13 amino acid residues (aa) vs. 9–12 aa in long-chain
neurotoxins), a shorter loop II (15–16 aa vs. 19–20 aa in long-
chain neurotoxins) and C-terminal tail (2 aa vs. 7–24 aa in long-
chain neurotoxins) when compared to long-chain neurotoxins.
This longer loop I of short-chain neurotoxins contains key
functional residues that are important for recognizing the nicotinic
acetylcholine receptor [55,56], while shorter loop I of long-chain
neurotoxins lacks these functional residues. The long C-terminal
tail appears to ‘substitute’ for the loop I functional residues and
contribute to the receptor binding [57,58]. The deletion of this C-
terminal tail reduces the binding affinity [59,60]. Similarly, the
difference in the conformations of the three loops appears to
dictate the biological specificities of these neurotoxins. Both short-
chain and long-chain neurotoxins exhibit equi-potency towards
muscle abcd nAChR [56,60] but only long-chain neurotoxins, not
short-chain neurotoxins, bind to neuronal a7 nAChR with high
affinity [61,62]. Detailed structure-function studies indicate that
the presence of the fifth disulfide bond in loop II enables long-
chain neurotoxins to recognize a7 nAChR. The short helical
segment formed by the fifth disulfide is thought to be crucial for
the target receptor recognition [62,63]. Thus, size and conforma-
tion of the loops indeed affects the interaction of neurotoxins with
their receptor. Similarly, structures of loop I in fasciculin [64], and
loop III in FS2 [65] and dendroaspin [66] have distinct
conformations. Hence, subtle conformational differences in the
loops of 3FTxs may help in identifying putative functions.
Hemachatoxin shows highest similarity to P-type cardiotoxins
[67] (Figure 2A). Similar to these P-type cardiotoxins, hemacha-
toxin has the conserved Pro31 and cytolytic site. The three-
dimensional structure is similar to P-type cardiotoxins (Figure 4B)
(RMSD values, 0.8 to 2.1 A˚ for 58 to 60 Ca atoms; Z score values,
12.2 to 9.8). Besides, hemachatoxin shows considerable structural
identity with S-type cardiotoxins (RMSD 1.1 to 2.8 for 58 to 59
Ca atoms; Z score values, 10.5 to 6.3) (data not shown). However,
the similarity with other groups of 3FTxs, such as neurotoxins,
muscarinic toxins, fasciculin, FS2 or dendroaspin, is relatively low
(Figure 2B, Table 2). The P-type cardiotoxins bind to phospho-
lipids and perturb the membrane surface with their lipid binding
sites (6–13, 24–37 and 46–50 amino acid positions in the tip of
loop I, II and III, respectively) [67–69]. These hydrophobic
residues flanked by cationic residues form cytolytic region in
Figure 3. Structure of hemachatoxin. (A) Ribbon representation of the hemachatoxin monomer. Cysteine bonds are shown in yellow. b-strands,
N- and C- terminals are labeled. (B) Electron density map. A sample final 2Fo-Fc map of hemachatoxin shows the region from Tyr23 to Lys29. The map
is contoured at a level of 1s. (C) The electrostatic surface potential of hemachatoxin is shown in the same orientation as Figure 3A. Blue indicates
positive potential and red indicates negative potential in units kT/e. All the structure related figures of this paper were prepared using the program
PyMol [77].
doi:10.1371/journal.pone.0048112.g003
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cardiotoxins [70,71]. We compared the B values of the cardiotoxin
loops with those of hemachatoxin. All three loops in P-type
cardiotoxins showed a high B value (an increase of 5–8 A˚2)
compared with the rest of the molecule. A similar increase in B
values (upto 8 A˚2 increase) was also observed in hemachatoxin
loops. Only loop II has the crystal contact suggesting that the
observed increase in B values might be limited by the symmetry
contacts. Nonetheless this analysis suggests that loop II is flexible
and may remain flexible until its interaction with membrane
phospholipids. These structural analyses also suggest that hema-
chatoxin might be having cardiotoxic/cytotoxic activity and our
future experiments will be directed to characterize the activity of
hemachatoxin.
Conclusion
In summary we report the isolation, purification and structural
characterization of a new 3FTx, hemachatoxin from H.
haemachatus venom. The structural and sequence analysis reveals
hemachatoxin to be a P-type cardiotoxin. Close comparison of the
loops of hemachatoxin with other 3FTxs suggests that hemacha-
toxin has structural features similar to the well characterized
cardiotoxins. The structural analysis combined with literature
predicts hemachatoxin to have cardiotoxic/cytotoxic properties.
Additional experiments are required to fully characterize the
activity of hemachatoxin.
Materials and Methods
Protein Purification
Lyophilized H. haemachatus crude venom was purchased from
South African Venom Suppliers (Louis Trichardt, South Africa).
Size-fractionation of the crude venom (100 mg in 1 ml of distilled
water) was carried out on a Superdex 30 gel-filtration column
(1.6660 cm) pre-equilibrated with 50 mM Tris-HCl buffer
(pH 7.4). The proteins were eluted with the same buffer using
an A¨KTA purifier system (GE Healthcare, Uppsala, Sweden).
Peak 3 from the gel-filtration chromatography was sub-fraction-
ated by reverse phase–high performance liquid chromatography
(RP-HPLC) on a Jupiter C18 column (106250 mm) equilibrated
with solvent A (0.1% TFA). The bound proteins were eluted using
a linear gradient of 28–50% solvent B (80% acetonitrile in 0.1%
TFA). The mass of each fraction were analyzed on a LCQ FleetTM
Ion Trap LC/MS system (Thermo Scientific, San Jose, USA).
XcaliburTM 2.1 and ProMass deconvolution 2.8 software were
used, respectively, to analyze and deconvolute the raw mass data.
The peak corresponding to hemachatoxin was pooled and re-
chromatographed using a shallow gradient of 35–45% solvent B
on the same column. The mass and homogeneity of purified
hemachatoxin was analyzed as described above.
Sequencing
Hemachatoxin (1.2 mg) was dissolved in 500 ml of denaturation
buffer (130 mM Tris-HCl pH 8.5, 1 mM EDTA, 6 M guanidine
HCl). After the addition of the reducing agent b-mercaptoethanol
(1.23 ml; 256molar excess of disulfide bonds), the reaction mixture
was incubated under a nitrogen stream for 3 h at room
temperature. Subsequently, the alkylating reagent 4-vinylpyridine
(5.7 ml; 36molar excess of b-mercaptoethanol) was added and
incubated under a nitrogen stream for another 2 h at room
temperature. The S-pyridylethylated protein was immediately
separated from the reaction mixture by RP-HPLC on a Jupiter
C18 column (4.66250 mm) using a linear gradient of 20–60%
solvent B and the mass was determined by ESI-MS as discussed
above. For cyanogen bromide (CNBr) cleavage, the S-pyridy-
lethylated protein (0.82 mg) was dissolved in 410 ml of 70% TFA
to which CNBr (67.7 ml in 70% TFA) was added in order to yield
a final protein concentration of 1 mg/ml. CNBr was used at a
molar ratio to methionine residue of 200:1. The reaction tube was
incubated in complete darkness for 24 h at room temperature.
After 24 h, 8.2 ml of Milli-Q water (106of reaction mixture) was
added into the reaction tube and, subsequently, the reaction tube
was lyophilized overnight [72]. The lyophilized sample was re-
solubilized in 3 ml of 0.1% TFA for separation by reverse-phase
chromatography on a Jupiter C18 column (4.66250 mm) using a
linear gradient of 10–50% solvent B. The masses of the peptide
fragments were determined by ESI-MS (data not shown). The N-
terminal sequence of native hemachatoxin and peptides generated
by CNBr cleavage (identified by mass spectrometry data) were
determined by automated Edman degradation using a PerkinEl-
mer Life Sciences Model 494 pulsed liquid-phase sequencer
(Procise, Foster City, USA) with an on-line Model 785A
phenylthiohydantoin-derivative analyzer. The complete amino
Table 1. Crystallographic data and refinement statistics.
Data collection*
Unit Cell (A˚) a = 49.7, b = 50.1, c = 57.8
Resolution range (A˚) 50-2.43 (2.47-2.43)
Wavelength (A˚) 1.5418
Observed reflections 28936
Unique reflections 5614
Completeness (%) 96.2 (84.5)
Redundancy 3.9 (3.7)
aRsym 0.06 (0.17)
I/SigI 20.6 (11.7)
Refinement
Resolution range (A˚) I.s(I) 30–2.43
bRwork 0.23
cRfree 0.28
Root mean square deviation
Bond lengths (A˚) 0.008
Bond angles (u) 1.377
Average B-factors (A˚2)
Protein atoms (938 atoms) 40.30
Water molecules (62 atoms) 37.1
Wilson B value 36.54
Ramachandran statistics
Most favored regions (%) 98.31
Allowed regions (%) 1.69
Disallowed regions (%) 0
Statistics from the current model.
aRsym =S|Ii2,I.|/S|Ii| where Ii is the intensity of the i
th measurement, and ,I.
is the mean intensity for that reflection.
bRwork =S| Fobs2Fcalc|/S|Fobs| where Fcalc and Fobs are the calculated and
observed structure factor amplitudes, respectively.
cRfree = as for Rwork, but for 10.0% of the total reflections chosen at random and
omitted from refinement.
*Values in the parenthesis are the highest resolution bin values.
doi:10.1371/journal.pone.0048112.t001
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acid sequence of hemachatoxin was determined by overlapping
sequences.
Crystallization and Structure Determination
Crystallization screens were performed with the hanging drop
vapor diffusion method using Hampton Research and Jena
Bioscience screens. The protein was at a concentration of
35 mg/ml, and 1:1 crystallization drops were set up with the
reservoir solution. The diffraction quality crystals of hemacha-
toxin were obtained from a reservoir solution containing 150 mM
ammonium acetate, 100 mM sodium acetate (pH 4.6) and 25%
polyethylene glycol 4000. Crystals were grown up to 10 days and
were cryo-protected with 20% (w/v) glycerol supplemented (the
mother liquor concentration was maintained by exchanging
water with glycerol) with the crystallization condition. Hemacha-
toxin crystal diffracted up to 2.43 A˚ resolution and belongs to
P212121 space group. A complete data set was collected using an
R-Axis IV++ image plate mounted on a rotating anode Rigaku X-
ray generator. The data set was processed and scaled using
HKL2000 [73]. The structure of hemachatoxin was determined
by the molecular replacement method using the program Phaser
[74]. The coordinates of Naja nigricollis toxin-c monomer structure
(PDB code 1TGX; sequence identity 67%) were used as a search
model. The structure solution was obtained with LLG- 94; and
TFZ score of 12.3 and RFZ score 4.5. Initial rigid body
refinement gave Rwork 36.6 (Rfree 43.5). There were two
hemachatoxin molecules located in the asymmetric unit. The
resultant electron density map was of good quality. Several cycles
of model building/refitting using the program Coot [75], and
alternated with refinement using the program Phenix [76], lead
to the convergence of R-values (Table 1). Non-crystallographic
symmetry (NCS) restraints were used throughout the refinement
process.
Accession Numbers
The protein sequence data reported in this paper will appear in
the UniProt Knowledgebase under the accession number
B3EWH9. The three dimensional coordinates and structure
factors of hemachatoxin were deposited in the RCSB (www.pdb.
org) database with the access code 3VTS.
Supporting Information
Figure S1 Reduction and pyridylethylation of hemacha-
toxin. (A) The S-pyridylethylated hemachatoxin (black arrow) was
purified on a linear gradient of 20–60% solvent B. (B) The ESI-
MS profile of S-pyridylethylated hemachatoxin showing the four
peaks of mass/charge (m/z) ratio ranging from +4 to +7 charges.
The mass was determined to be 7685.1261.14 Da.
(TIF)
Figure S2 Separation of peptides derived from cyano-
gen bromide cleavage of the S-pyridylethylated hema-
chatoxin on RP-HPLC. A linear gradient of 10–50% solvent B
was used. The peptides A and B were sequenced by Edman
degradation method.
(TIF)
Figure 4. Comparison of hemachatoxin with other three-finger toxins. (A) Structure based sequence alignment of hemachatoxin and its
homologs, cardiotoxin 3 (1H0J), cytotoxin 3 (1XT3), cardiotoxin A3 (2BHI), cardiotoxin VI (1UG4) and cardiotoxin V (1KXI), (all from Naja atra),
cardiotoxin VII4 (1CDT) from Naja mossambica and toxin-c (1TGX) (a cardiotoxin from Naja nigricollis). This figure was generated using the programs
ClustalW [78] and ESPript [79]. (B) Comparison of hemachatoxin with its structural homologs. Hemachatoxin (brown), cardiotoxin 3 [1H0J] (cyan),
cytotoxin 3 [1XT3] (black), carditotoxin A3 [2BHI] (blue), cardiotoxin VI [1UG4] (red), cardiototoxin V [1KXI] (pink), cardiotoxin VII4 [1CDT] (green) and
toxin-c [1TGX] (yellow).
doi:10.1371/journal.pone.0048112.g004
Table 2. Structural similarity of hemachatoxin with 3FTxs.
Protein Source PDB RMSD* Z score Reference
Cardiotoxin V Naja atra 1KXI 1.1 A˚(60) 12.2 [49]
Cardiotoxin A3 Naja atra 2BHI 0.8 A˚(59) 12.0 [50]
Cardiotoxin 3 Naja atra 1H0J 0.9 A˚(59) 11.7 [51]
Cytotoxin 3 Naja atra 1XT3 0.8 A˚(59) 11.6 [80]
Toxin-c Naja atra 1TGX 1.6 A˚(59) 11.1 [52]
Cardiotoxin VI Naja atra 1UG4 1.8 A˚(59) 11 [81]
Cardiotoxin VII4 Naja atra 1CDT 1.1 A˚(58) 10.5 [82]
Cytotoxin 2 Naja naja oxiana 1CCQ 2.1 A˚(59) 9.8 [83]
Muscarinic M1 toxin Dendroaspis angusticeps 2VLW 2.4 A˚(55) 9.1 [84]
Haditioxin Ophiophagus hannah 3HH7 2.4 A˚(58) 8.5 [15]
a-bungarotoxin Bungarus multicinctus 2QC1 2.4 A˚(58) 8.4 [85]
Erabutoxin A Laticauda semifasciata 3ERA 2.3 A˚(56) 7.9 [86]
Fasciculin 2 Dendroaspis angusticeps 1FSC 2.3 A˚(55) 7.5 [87]
Toxin FS2 Dendroaspis polylepis polylepis 1TFS 2.9 A˚(56) 7.4 [65]
Dendroaspin Dendroaspis jamesoni kaimosae 1DRS 3.5 A˚(49) 3.6 [66]
*Number of Ca atoms superimposed given in the parenthesis.
doi:10.1371/journal.pone.0048112.t002
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Figure S3 Chromatographic profiles of PTH-amino acid
(phenylthiohydantoin-amino acid) residues 27 and 28 of
the Edman degradation cycles 29 and 30. (A) Elution
profile of standard PTH-amino acid residues. (B) Cycle 29 of
Edman degradation showing the 27th residue, PTH-L. PTH-T
and PTH-M denotes the carryover from 28th and 27th cycle,
respectively. (C) Cycle 30 of Edman degradation showing the 28th
residue, PTH-M. PTH-L denote the carryover from 29th cycle.
(TIF)
Table S1 The sequence determination of hemacha-
toxin.
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